查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944410

全球出血性和缺血性中風治療設備市場（按設備類型、治療類型、最終用戶、技術、國家和地區分類）—產業分析、市場規模、市場佔有率和產業預測（2025-2032年）

Hemorrhagic & Ischemic Stroke Treatment Devices Market, By Device Type, By Treatment Type, By End User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，出血性和缺血性中風治療設備市場規模將達到 36.1098 億美元，並預計從 2025 年到 2032 年將以 6.10% 的複合年成長率成長。

出血性和缺血性中風治療器械是專門用於診斷、干預和治療由腦出血（出血）或缺血（閉塞）引起的急性中風的醫療設備。這些器械包括神經血管支架、血栓切除系統、栓塞彈簧圈、血流導向裝置、微導管和顱內壓監測器，能夠實現微創血管內手術，進而恢復血流並控制出血。現代卒中治療器材強調精準導航、先進的影像整合、生物相容性材料和更高的安全性。創新重點在於人工智慧輔助的影像導引介入治療、新一代血栓切除工具和增強的止血技術。人口老化和生活方式因素導致中風發病率上升，中風治療基礎設施不斷完善，有利的報銷政策，以及發達和新興醫療體系中微創手術的日益普及，都為卒中治療器械的市場發展帶來了機會。

出血性和缺血性中風治療器材市場—市場動態

市場需求受企業數位化、文件安全需求和成本效益的驅動。

企業和政府機構的數位轉型正在加速對快速、安全且經濟高效的列印解決方案的需求。根據IDC預測，到2023年，全球辦公室列印量將超過2.3兆頁，其中雷射印表機憑藉其低單頁成本和在高負載環境下的耐用性將佔據主導地位。安全性問題也是推動雷射印表機普及的重要因素。 IBM發布的《2024年資料外洩成本報告》顯示，82%的資料外洩是由人為錯誤造成的，包括文件處理不當，這迫使企業部署具備安全列印釋放、加密和存取控制功能的雷射列印系統。此外，預計到2024年，全球企業在託管列印服務（MPS）方面的IT支出將超過550億美元，反映出企業正大力轉向集中高效的列印管理。混合辦公模式的普及和多功能雷射印表機的日益普及也在推動市場成長，因為企業越來越需要可靠、互聯且節能的列印基礎設施。

出血性和缺血性中風治療設備市場—市場區隔分析：

全球出血性和缺血性中風治療設備市場按設備類型、治療方法、最終用戶、技術和地區進行細分。

依器械類型分類，市場可分為機械血栓除去裝置、動脈瘤栓塞和夾閉器械、溶栓藥物傳輸系統、血栓摘取支架和止血器械。機械血栓除去裝置因其在缺血性中風治療中的重要作用而佔據市場主導地位。根據世界衛生組織（WHO）統計，缺血性中風約佔全球中風病例的65%。微創動脈瘤栓塞和夾閉器械在出血性中風的治療中至關重要，出血性中風約佔全球中風病例的30%。溶栓藥物傳輸系統仍是缺血性中風早期治療方法。血栓摘取支架和止血器械進一步提高了中風介入治療的手術效果和安全性。

根據治療類型，市場可分為缺血性中風治療和出血性中風治療兩大板塊。缺血性中風治療板塊佔最大佔有率，這與全球缺血性中風的發生率相符。根據2021年全球疾病負擔研究（GBD）的估計，全球每年新增缺血性中風病例約780萬例。出血性中風治療（包括腦出血和蜘蛛膜下腔出血）每年新增病例約400萬例，並且由於用於動脈瘤治療和出血控制的先進設備日益普及，該板塊一直保持穩定成長。

出血性和缺血性中風治療器械市場—區域分析

由於醫療基礎設施發展、政府衛生政策、中風盛行率和報銷政策等因素的影響，全球出血性和缺血性中風治療設備市場存在顯著的區域差異。

北美地區佔最大的市場佔有率，這得益於其先進的醫療基礎設施、微創中風治療方法的廣泛普及以及政府對中風治療的大力投入。根據美國疾病管制與預防中心（CDC）統計，美國每年約有79.5萬例新增中風病例，凸顯了對先進中風治療設備的需求。此外，聯邦醫療保險（Medicare）和私人保險公司提供的神經血管介入治療的全面保險也推動了市場成長。

歐洲的卒中發生率僅次於北美，位居第二，這主要得益於較高的公眾意識、完善的卒中中心以及政府推行的早期診斷和治療項目。根據歐洲卒中組織（ESO）統計，歐洲每年約有110萬例新增卒中病例，目前各成員國正努力實現卒中診療的標準化。

美國出血性和缺血性中風治療器械市場—國家分析

美國在全球出血性和缺血性中風治療設備市場主導，這主要得益於其高昂的醫療保健支出和先進的中風護理基礎設施。根據美國心臟協會（AHA）預測，到2023年，美國用於中風相關治療和復健的醫療費用支出預計將超過460億美元。

根據美國醫療保險和醫療補助服務中心 (CMS) 的報告，報銷政策越來越重視機械取栓術和血管內治療，截至 2022 年，全美每年大約進行 45,000 例取栓手術。此外，美國擁有 250 多個經聯合委員會認證的綜合中風中心，這使得尖端中風治療設備能夠迅速得到應用。

目錄

第1章 出血性和缺血性中風治療器械市場概覽

  • 調查範圍
  • 市場預測期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 出血性和缺血性中風治療器械市場：主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章 出血性和缺血性中風治療設備產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 法規結構分析

5. 出血性和缺血性中風治療器材市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：出血性和缺血性中風治療器材的市場概況

  • 2024年出血性和缺血性中風治療設備市佔率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 出血性和缺血性中風治療設備市場（依設備類型分類）

  • 概述
    • 按設備類型分類的細分市場佔有率分析
    • 機械血栓切除裝置
    • 動脈瘤栓塞及夾閉裝置
    • 溶栓藥物輸送系統
    • 血栓摘取支架
    • 止血裝置

8. 依治療類型分類的出血性和缺血性中風治療設備市場

  • 概述
    • 細分市場佔有率分析：依治療類型分類
    • 缺血性中風治療
    • 出血性中風治療

9. 依最終用戶分類的出血性和缺血性中風治療設備市場

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院
    • 門診手術中心
    • 專科診所

10. 依技術分類的出血性和缺血性中風治療設備市場

  • 概述
    • 細分市場佔有率分析：依技術分類
    • 基於導管的系統
    • 手術器械
    • 診斷影像和導航系統

第11章 出血性和缺血性中風器械市場（按地區分類）

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 主要供應商分析－出血性和缺血性中風器械產業

  • 競爭標竿分析
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Medtronic
    • Balt
    • Terumo Corporation
    • Scientia Vascular, Inc.
    • Johnson &Johnson（MedTech）
    • MicroPort Scientific Corporation
    • phenox GmbH（Wallaby Medical）
    • B. Braun SE
    • Acandis GmbH
    • Infinity Neuro LLC
    • Integra LifeSciences
    • Penumbra, Inc.
    • Stryker
    • Boston Scientific Corporation
    • Vesalio Inc.
    • Peter LAZIC GmbH
    • 其他

第13章：分析師視角

簡介目錄
Product Code: ANV5988

Hemorrhagic & ischemic stroke treatment devices market size was valued at US$ 3,610.98 Million in 2024, expanding at a CAGR of 6.10% from 2025 to 2032.

Hemorrhagic and ischemic stroke treatment devices are specialized medical instruments designed for the diagnosis, intervention, and management of acute stroke caused by cerebral hemorrhage (bleeding) or ischemia (blockage). These devices include neurovascular stents, thrombectomy systems, embolization coils, flow diverters, microcatheters, and intracranial pressure monitors, enabling minimally invasive endovascular procedures that restore blood flow or control bleeding. Modern stroke treatment devices emphasize precision navigation, advanced imaging integration, biocompatible materials, and improved safety profiles. Innovations focus on AI-assisted image-guided interventions, next-generation thrombectomy tools, and enhanced hemostatic technologies. Market opportunities arise from growing stroke incidence due to aging populations and lifestyle factors, expanding stroke care infrastructure, favorable reimbursement policies, and increased adoption of minimally invasive procedures in both developed and emerging healthcare systems.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Market Dynamics

Growing enterprise digitization, document security needs, and cost-efficiency to propel market demand

Rising digital transformation across enterprises and government institutions is accelerating demand for high-speed, secure, and cost-efficient printing solutions. According to IDC, global office printing volumes exceeded 2.3 trillion pages in 2023, with laser printers accounting for the majority due to lower cost per page and higher durability in high-volume environments. Security concerns are also driving adoption. IBM's Cost of a Data Breach Report 2024 states that 82% of data breaches involve human error, including document mishandling, pushing organizations to adopt secure print release, encryption, and access-controlled laser printing systems. Additionally, enterprise IT spending on managed print services (MPS) crossed USD 55 billion globally in 2024, reflecting a strong shift toward centralized, efficient print management. The growing adoption of hybrid work models and multifunction laser printers further supports market growth, as organizations seek reliable, network-connected, and energy-efficient printing infrastructure.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Segmentation Analysis:

The Global Hemorrhagic & Ischemic Stroke Treatment Devices Market is segmented on the basis of Device Type, Treatment Type, End User, Technology, and Region.

Based on Device Type, the market is categorized into Mechanical Thrombectomy Devices, Aneurysm Coiling and Clipping Devices, Thrombolytic Drug Delivery Systems, Stent Retrievers, and Hemostasis Devices. Mechanical thrombectomy devices dominate the market due to their critical role in treating ischemic strokes, which constitute approximately 65% of all stroke cases globally, according to the World Health Organization (WHO). Minimally invasive aneurysm coiling and clipping devices are essential for managing hemorrhagic strokes, which make up nearly 30% of stroke cases worldwide. Thrombolytic drug delivery systems remain a standard of care for early ischemic stroke treatment. Stent retrievers and hemostasis devices further enhance procedural outcomes and safety during stroke interventions.

Based on Treatment Type, the market is divided into Ischemic Stroke Treatment and Hemorrhagic Stroke Treatment segments. The ischemic stroke treatment segment holds the largest share, consistent with the global incidence of ischemic strokes accounting for about 7.8 million new cases annually, as estimated by the Global Burden of Disease (GBD) study 2021. Hemorrhagic stroke treatment, covering intracerebral and subarachnoid hemorrhages, which together account for around 4 million new cases per year, is witnessing steady growth with rising adoption of advanced devices for aneurysm management and bleeding control.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Geographical Insights

The global hemorrhagic and ischemic stroke treatment devices market shows significant regional variation influenced by healthcare infrastructure development, government health initiatives, stroke prevalence, and reimbursement policies.

North America holds the largest market share, supported by advanced healthcare infrastructure, widespread adoption of minimally invasive stroke interventions, and strong government funding for stroke care. According to the Centers for Disease Control and Prevention (CDC), the United States reports approximately 795,000 new stroke cases annually, emphasizing the need for sophisticated stroke treatment devices. Additionally, Medicare and private insurers provide comprehensive coverage for neurovascular interventions, bolstering market growth.

Europe follows closely, driven by high awareness levels, well-established stroke centers, and government programs promoting early stroke diagnosis and treatment. The European Stroke Organisation (ESO) notes that Europe experiences about 1.1 million new stroke cases each year, with ongoing efforts to standardize stroke care across member countries.

U.S. Hemorrhagic & Ischemic Stroke Treatment Devices Market- Country Insights

The United States dominates the global hemorrhagic and ischemic stroke treatment devices market, supported by substantial healthcare expenditure and advanced stroke care infrastructure. In 2023, the U.S. healthcare spending on stroke-related treatments and rehabilitation exceeded USD 46 billion, according to the American Heart Association (AHA).

The Centers for Medicare & Medicaid Services (CMS) reports that reimbursement policies increasingly favor mechanical thrombectomy and endovascular procedures, with nearly 45,000 thrombectomy procedures performed annually across the country as of 2022. Additionally, the U.S. has over 250 Comprehensive Stroke Centers certified by The Joint Commission, enabling rapid adoption of state-of-the-art stroke intervention devices.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Competitive Landscape:

Rising stroke prevalence, technological advancements, and increasing demand for minimally invasive treatment options are intensifying competition across the global stroke treatment device ecosystem. Major players include Medtronic, Balt, Terumo Corporation, Scientia Vascular, Inc., Johnson & Johnson (MedTech), MicroPort Scientific Corporation, phenox GmbH (Wallaby Medical), B. Braun SE, and others. These companies compete through device innovation, clinical efficacy, regulatory approvals, and extensive sales and distribution networks. Common strategies include expanding portfolios of thrombectomy systems, aneurysm coiling and clipping devices, investing in AI-powered image-guided intervention technologies, and enhancing catheter and stent designs for improved patient outcomes. Many firms are also focusing on strategic partnerships with healthcare providers and research institutions to accelerate clinical trials and adoption, while emphasizing compliance with evolving global regulatory standards and reimbursement frameworks.

Recent Developments:

In January 2026, Penumbra introduced the Lightning Flash 3.0 computer assisted vacuum thrombectomy (CAVT(TM)) system, featuring enhanced clot detection, enlarged tubing, and automated backflush for faster, safer clot removal. The upgrade aims to improve procedural efficiency and fluid management, building on prior CAVT advancements in mechanical thrombectomy technology.

In February 2025, Johnson & Johnson MedTech launched the CEREGLIDE(TM) 92 Catheter System in the U.S., a next generation .092" large bore neurovascular catheter with INNERGLIDE(TM) 9 delivery aid. Designed for improved distal access and flow reduction during acute ischemic stroke interventions, it supports enhanced device navigation and integration with stroke device portfolios.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic
  • Balt
  • Terumo Corporation
  • Scientia Vascular, Inc.
  • Johnson & Johnson (MedTech)
  • MicroPort Scientific Corporation
  • phenox GmbH (Wallaby Medical)
  • B. Braun SE
  • Acandis GmbH
  • Infinity Neuro LLC
  • Integra LifeSciences
  • Penumbra, Inc.
  • Stryker
  • Boston Scientific Corporation
  • Vesalio Inc.
  • Peter LAZIC GmbH
  • Others

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Mechanical Thrombectomy Devices
  • Aneurysm Coiling and Clipping Devices
  • Thrombolytic Drug Delivery Systems
  • Stent Retrievers
  • Hemostasis Devices

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Ischemic Stroke Treatment
  • Hemorrhagic Stroke Treatment

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Catheter-Based Systems
  • Surgical Instruments
  • Imaging and Navigation Systems

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Device Type
    • 2.1.2. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Treatment Type
    • 2.1.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by End User
    • 2.1.4. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Technology
    • 2.1.5. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Country
    • 2.1.6. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemorrhagic & Ischemic Stroke Treatment Devices Key Market Trends

  • 3.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemorrhagic & Ischemic Stroke Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Opportunities
  • 3.4. Hemorrhagic & Ischemic Stroke Treatment Devices Market Future Trends

4. Hemorrhagic & Ischemic Stroke Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hemorrhagic & Ischemic Stroke Treatment Devices Market Landscape

  • 6.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Device Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Device Type, 2024 & 2032 (%)
    • 7.1.2. Mechanical Thrombectomy Devices
    • 7.1.3. Aneurysm Coiling and Clipping Devices
    • 7.1.4. Thrombolytic Drug Delivery Systems
    • 7.1.5. Stent Retrievers
    • 7.1.6. Hemostasis Devices

8. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 8.1.2. Ischemic Stroke Treatment
    • 8.1.3. Hemorrhagic Stroke Treatment

9. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics

10. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 10.1.2. Catheter-Based Systems
    • 10.1.3. Surgical Instruments
    • 10.1.4. Imaging and Navigation Systems

11. Hemorrhagic & Ischemic Stroke Treatment Devices Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hemorrhagic & Ischemic Stroke Treatment Devices Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Medtronic
    • 12.2.2. Balt
    • 12.2.3. Terumo Corporation
    • 12.2.4. Scientia Vascular, Inc.
    • 12.2.5. Johnson & Johnson (MedTech)
    • 12.2.6. MicroPort Scientific Corporation
    • 12.2.7. phenox GmbH (Wallaby Medical)
    • 12.2.8. B. Braun SE
    • 12.2.9. Acandis GmbH
    • 12.2.10. Infinity Neuro LLC
    • 12.2.11. Integra LifeSciences
    • 12.2.12. Penumbra, Inc.
    • 12.2.13. Stryker
    • 12.2.14. Boston Scientific Corporation
    • 12.2.15. Vesalio Inc.
    • 12.2.16. Peter LAZIC GmbH
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us